Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Newark, CA
SEC filing record 1 source field available
Fiscal year end
31 December
CymaBay Therapeutics, Inc. has filed 780 SEC EDGAR filings since 19 Feb 2002

SEC filing history

Showing 601-625 of 768 matching filings.

Per page
25
Current page
25
4

FORM 4 -

Filing date
28 Jan 2016
Reporting date
26 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
28 Jan 2016
Reporting date
26 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
28 Jan 2016
Reporting date
26 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
28 Jan 2016
Reporting date
26 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
28 Jan 2016
Reporting date
26 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
28 Jan 2016
Reporting date
26 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
28 Jan 2016
Reporting date
26 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
28 Jan 2016
Reporting date
26 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36500

FORM 8-K

Filing date
20 Jan 2016
Reporting date
20 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36500

CT ORDER filing

Filing date
15 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36500

FORM 8-K

Filing date
12 Nov 2015
Reporting date
12 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
08 Oct 2015
Reporting date
06 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36500

8-K

Filing date
08 Oct 2015
Reporting date
06 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
11 Sep 2015
Reporting date
09 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36500

FORM 8-K

Filing date
09 Sep 2015
Reporting date
02 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
17 Aug 2015
Reporting date
13 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-245800

D filing

Filing date
14 Aug 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36500

FORM 8-K

Filing date
10 Aug 2015
Reporting date
10 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Jul 2015
Reporting date
20 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36500

FORM 8-K

Filing date
15 Jul 2015
Reporting date
15 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-200006

PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE 424(B)(5)

Filing date
15 Jul 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-200006

PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE 424(B)(5)

Filing date
14 Jul 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
30 Jun 2015
Reporting date
24 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .